NEW YORK - Swiss drugmaker Novartis AG sued Amgen Inc on Thursday, accusing the U.S. biotechnology company of trying to back out of agreements to jointly develop and market Aimovig for the prevention of migraines, and keep the profits for itself.
In a complaint filed in Manhattan federal court, Novartis said it has spent several hundred million dollars on Aimovig since August 2015, when it began collaborating with Amgen, which previously controlled all rights to the treatment. Novartis called Aimovig a “runaway success,” with about 210,000 patients using the drug in the United States and another 20,000 patients elsewhere.The lawsuit seeks to enforce the companies’ collaboration agreements, and declare Amgen’s purported termination void.Roughly 39 million Americans suffer from migraine headaches, according to the Migraine Research Foundation.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Biogen SMA drug price, Novartis estimates for its treatment far too high - U.S. groupBiogen Inc should slash the price of its spinal muscular atrophy (SMA) drug, and...
Source: Reuters - 🏆 2. / 97 Read more »
'Fear' and health care: Gallup survey finds Americans skipped treatment, borrowed $88B to pay for costsA Gallup survey funded by West Health finds that Americans borrowed $88 billion to pay for health care last year Because both sides act like q bunch of petty children Lucille had a bad hip. I carried her feed to her for three straight days. We take care of each other. Regards Belle Herd director The only time Congress makes bipartisan solutions is to screw over Americans so I hope to god they don't.
Source: USATODAY - 🏆 100. / 63 Read more »
Amazon has quietly removed promotional spots that gave special treatment to its own productsAmazon has quietly removed some of its most aggressive promotions for private label products, following increased regulatory scrutiny of tech giants in recent months.
Source: CNBC - 🏆 12. / 72 Read more »
U.S. lawmakers urge sanctions over China's treatment of Muslim minorityA bipartisan group of U.S. lawmakers on Wednesday faulted the Trump administrati... Lol that won't happen. You don't bite the hand that feeds you. oh the irony... Brunei? Saudia Arabia?
Source: Reuters - 🏆 2. / 97 Read more »